XNAS · ONCO
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Onconetix, Inc. Common Stock

Onconetix, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$0.9555
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is ONCO moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Onconetix, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Listed since
2022
Employees
2
Country
US

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.9555
Last session
Day high
$0.9555
Last session
Day low
$0.9555
Last session
Previous close
$0.9555
52W high
$0.9555
0.00% from high
52W low
$0.9555
Market cap
$3.5M
EPS
$-18.2500
Shares out
3.7M
VWAP
$0.9555
Last session
Veridion warehouse edge

Warehouse intelligence for ONCO.

Veridion Score
Not reported
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

ONCO insider activity

Onconetix, Inc. Common Stock

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for ONCO.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

ONCO contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ONCO in this window.
Lobbying spend

ONCO lobbying filings, year to date.

Registered lobbying filings matched to Onconetix, Inc. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ONCO in this window.
Latest news · ONCO
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for ONCO.
Options
Sovereign unlock shows live options positioning for ONCO.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.